Vice President, Clinical Pharmacology @ (February 2020 - April 2022)
Sr. Director, DMPK and Clinical Pharmacology @ Peloton Therapeutics, a subsidiary of Merck & Co., Inc. (July 2019 - February 2020)
Director, DMPK @ Peloton Therapeutics (June 2016 - June 2019)
Senior Scientist @ Peloton Therapeutics (June 2013 - May 2016)
Investigator III and Lab Head @ (April 2006 - March 2013)
Principal Scientist @ Chiron Corporation (April 1999 - April 2006)
Postdoctoral Scholar @ (September 1996 - April 1999)
Keshi Wang Education
Washington University in St. Louis
Doctor of Philosophy (PhD) (Organic Chemistry)
1996
Keshi Wang Skills
Drug Metabolism
ADME
DMPK
Pharmacokinetics
Drug Discovery
Bioanalysis
In Vitro
Life Sciences
Oncology
Pharmaceutical Industry
Clinical Development
Assay Development
Drug Development
Science
Management
Investigation
Molecular Biology
In Vivo
Research
Winnonlin
Data Analysis
Lc Ms
Phoenix Winnonlin
Keshi Wang Summary
Keshi Wang, based in San Mateo, CA, US, is currently a Senior Vice President, Clinical Pharmacology at BBOT. Keshi Wang brings experience from previous roles at BridgeBio, NiKang Therapeutics Inc., Peloton Therapeutics, a subsidiary of Merck & Co., Inc. and Peloton Therapeutics. Keshi Wang holds a Doctor of Philosophy (PhD) in Organic Chemistry @ Washington University in St. Louis. With a robust skill set that includes Drug Metabolism, ADME, DMPK, Pharmacokinetics, Drug Discovery and more. Keshi Wang has 5 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Keshi Wang?
Find contact details for 700 million professionals.